Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sol-Gel Technologies Ltd
(NQ:
SLGL
)
0.7900
-0.0310 (-3.78%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,002
Open
0.8499
Bid (Size)
0.6957 (12)
Ask (Size)
0.8288 (6)
Prev. Close
0.8210
Today's Range
0.7900 - 0.8514
52wk Range
0.6311 - 4.010
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024
May 20, 2024
SLGL stock results show that Sol-Gel Technologies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Week in Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
May 19, 2024
In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
Via
Talk Markets
Performance
YTD
-35.25%
-35.25%
1 Month
-4.82%
-4.82%
3 Month
-15.51%
-15.51%
6 Month
-32.48%
-32.48%
1 Year
-79.64%
-79.64%
More News
Read More
Sol-Gel Technologies: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Recap: Sol-Gel Technologies Q3 Earnings
November 09, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Via
Benzinga
Expert Ratings for Sol-Gel Technologies
August 11, 2023
Via
Benzinga
Sol-Gel Technologies: Q1 Earnings Insights
May 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Via
Benzinga
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) Making Surprising Moves in Wednesday Session
March 22, 2023
Via
Investor Brand Network
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
Via
InvestorPlace
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Via
Benzinga
The Top 7 Penny Stocks to Invest in for the Long-Term
February 23, 2023
Via
InvestorPlace
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
Via
Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
November 07, 2022
Via
Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
October 24, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Via
Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
June 29, 2022
Via
Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
July 15, 2022
Via
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Via
Benzinga
Earnings Scheduled For August 4, 2021
August 04, 2021
Via
Benzinga
Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris
July 27, 2021
Via
Benzinga
Exposures
Product Safety
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
June 28, 2021
From
Galderma
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.